TOP STORIES

• BUSINESS Eylea Bio-AG Snags 60% Share in Just 3 Months, Outpacing Biosimilar
  May 29, 2026

• ORGANIZATION Global Pharma CEOs Urge Japan PM to Boost Support for Innovative Drugs
  May 29, 2026

• BUSINESS Bayer Regulatory Chief Hails Japan’s Review System, Flexibility on PI Waivers
  May 28, 2026

• BUSINESS Astellas Sees Sales Decline through FY2029 on Xtandi LOE, Maps 200 Billion Yen Cuts in 5 Years
  May 27, 2026

• REGULATORY LDP Panel OKs Immunization Act Bill Aimed at Beyfortus NIP Use
  May 27, 2026

• REGULATORY US Calls Out Japan’s Market Expansion Re-Pricing Rules as “Unfair”: IP Report
  May 26, 2026

• COMMENTARY Are Technical Discussions Enough for Japan’s CEA System?
  May 25, 2026

• BUSINESS Japan Market Hits Record 11.8 Trillion Yen in FY2025, Keytruda Keeps Title: IQVIA
  May 22, 2026

• BUSINESS Kissei Drops Call to Halt New Tavneos Use after Blue Letter Action
  May 22, 2026

• REGULATORY Update: Tavneos Slapped with Blue Letter Action in Japan over Liver Injury Risk
  May 22, 2026

• ORGANIZATION Novartis’ Pullicino to Helm EFPIA Japan from July
  May 22, 2026

• BUSINESS BMS, Nikon Pitch Japan-to-Asia Cell Therapy Push, Draw Support at Policy Forum
  May 21, 2026

• BUSINESS Sanofi Eyes Double-Digit Annual Growth for Japan Vaccine Business: Exec
  May 20, 2026

• REGULATORY Japan to Start CEA Technical Discussions as Early as May 25
  May 20, 2026

• REGULATORY Japan Approves Jascayd, mNEXSPIKE, Zepbound OSA Use, Others
  May 19, 2026

• REGULATORY Wegovy’s MASH Label Expansion and More Up for Japan Panel Review on May 29
  May 18, 2026

• BUSINESS Kissei Urges Halt to New Tavneos Use after Fatal Liver Injury Reports
  May 18, 2026

• REGULATORY MHLW Official Says US MFN Policy Could Be Taken Up by Chuikyo
  May 15, 2026

• REGULATORY Japan to Launch CEA “Technical Discussions” under MHLW Research Group
  May 14, 2026

• REGULATORY Mounjaro Hit with 25% Price Cut under Japan’s “SPA-SSS” Re-Pricing
  May 14, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »